Treatment Strategies for IgG4-RD Patients With Superficial Organ Involvement

NCT05789030 · clinicaltrials.gov ↗

NA

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Autoimmune Diseases

Interventions

DRUG: glucocorticoid plus iguratimod
DRUG: glucocorticoid plus leflunomide

Sponsor

Peking Union Medical College Hospital